GSK loses Advair (fluticasone/salmeterol) case in Netherland.
…GSK said in a statement a court in The Hague had ruled in favour of joint claimants, Novartis units Sandoz BV and Hexal AG, in deciding that the Dutch part of the European patent for Advair, as well as the supplementary protection certificate (SPC), was not valid…
– GSK says considering appeal to a higher court
– Ruling in favour of Novartis units Sandoz, Hexal
Detailed post could be found at Kluwer Patent Blog
English translated version of Advair duch court decision (The SPC blog)
Patent: EP0416951 (Expires with SPC Sep 06, 2013)